≥90% , 112137-89-0
| Pack Size | Price | Stock | Quantity |
| 1mg | RMB958.85 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Boiling point: | 538.3±50.0 °C(Predicted) |
| Density | 1.118±0.06 g/cm3(Predicted) |
| storage temp. | -20°C |
| solubility | Chloroform |
| pka | 4.77±0.10(Predicted) |
| form | Yellow viscous oil. |
| color | Pale Yellow |
| Stability: | Temperature Sensitive |
Description and Uses
Misoprostol is a prostaglandin E1 analog with agonist activity mediated by EP2, EP3, and EP4 receptors. It has been shown to inhibit the formation of gastric lesions in rats (ED50 = 0.31 μg/kg), inhibit superoxide generation in human neutrophils (EC50 = 0.35 μM), and relax fetal rabbit ductus arteriosus (EC50 = 0.36 nM) in a concentration dependent manner. Misoprostol is commonly used in clinical medicine for the prevention of peptic ulcer disease. It has also been used in conjunction with mifepristone (RU-
Misoprostol Acid is a prostaglandin E1 analog with agonist activity mediated by EP2, EP3, and EP4 receptors. It has been shown to inhibit the formation of gastric lesions in rats (ED50 = 0.31 μg/kg), inhibit superoxide generation in human neutrophils (EC50 = 0.35 μM), and relax fetal rabbit ductus arteriosus (EC50 = 0.36 nM) in a concentration dependent manner. Misoprostol is commonly used in clinical medicine for the prevention of peptic ulcer disease. It has also been used in conjunction with mifepristone (RU-486; ) for the oral induction of first trimester abortion. Misoprostol contains a C-1 methyl ester and is readily absorbed and rapidly hydrolyzed in humans to the active free acid.
Safety
| Symbol(GHS) |   GHS06,GHS08 |
| Signal word | Danger |
| Hazard statements | H301-H315-H319-H335-H361 |
| Precautionary statements | P201-P301+P310+P330-P302+P352-P305+P351+P338 |
| Hazard Codes | T |
| Risk Statements | 45-60-61-25-36/37/38 |
| Safety Statements | 53-22-36/37/39-45-26 |
| RIDADR | UN 2810 6.1/PG 3 |
| WGK Germany | 2 |
| HazardClass | 6.1 |
